尼群地平(Nitrendipine,硝苯乙吡啶)为双氢吡啶类衍生物,属第二代钙拮抗剂,是一个有希望的、口服有效、毒副作用较小的抗高血压新药。我们对43例高血压患者应用此药治疗,现将结果报告如下: 资料和方法一、病例选择高血压患者43例,诊断符合1979年标准,其中住院患者25例,门诊患者18例。全组男25例、女18例,年龄23～76(平均51.9)岁,其中≥60岁者15例。病程1～32年。43例中高血压病40 Nitrendipine, a derivative of dihydropyridine, is a second-generation calcium antagonist. It is a promising anti-hypertensive drug with low toxicity and side effects. We applied the drug to 43 hypertensive patients and the results are reported as follows: Materials and Methods 1. Case Selection 43 patients with hypertension were diagnosed in accordance with the 1979 standard, including 25 inpatients and 18 outpatients. The whole group of 25 males and 18 females, aged 23 to 76 (average 51.9) years old, of which ≥ 60 years in 15 cases. Duration of 1 to 32 years. 43 cases of hypertension 40